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The carcinogenicity of cadmium, arsenic, and chromium(VI) compounds has been recognized for some
decades. However, the underlying molecular mechanisms seem to be complex and are not completely
understood at present. Although, with the exception of chromium(VI), direct DNA damage seems to be
of minor importance, interactions with DNA repair processes, tumor suppressor functions, and signal
transduction pathways have been described in diverse biological systems. In addition to the induction
of damage to cellular macromolecules by reactive oxygen species, the interference with cellular redox
regulation by reaction with redox-sensitive protein domains or amino acids may provide one plausible
mechanism involved in metal carcinogenicity. Consequences are the distortion of zinc-binding
structures and the activation or inactivation of redox-regulated signal transduction pathways,
provoking metal-induced genomic instability. Nevertheless, the relevance of the respective mechan-
isms depends on the actual metal or metal species under consideration and more research is needed to
further strengthen this hypothesis.
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Many metal compounds are carcinogenic to humans and
to experimental animals. This applies not only to toxic metal9
-NC-ND license.compounds such as cadmium, lead, arsenic, and antimony, but
includes also essential trace elements such as chromium, nickel,
and cobalt on conditions of metal overload, exceeding the
homeostatic capacity [1]. Nevertheless, with the exception of
Cr(VI), most metal compounds are not mutagenic in bacterial
test systems and mutagenic responses in mammalian cells
are rather weak. Therefore, again with the exception of Cr(VI),
direct interactions of metal ions with DNA seem to be of minor
A. Hartwig / Free Radical Biology and Medicine 55 (2013) 63–7264importance [1]. One mechanism frequently proposed to be
involved in metal-induced tumor formation is an increase in
reactive oxygen species and oxidatively damaged DNA. In addi-
tion, interference with the cellular response to DNA damage and
with distinct signaling pathways has been identiﬁed for many
metal compounds during the past years, including interactions
with various types of DNA repair systems, cell cycle control, and
tumor suppressor functions, as well as with cell proliferation and
cell death [1–6]. In many cases, the inactivation of distinct
proteins of the respective pathways has been demonstrated. For
example, proteins with zinc-binding domains, so-called zinc-
ﬁnger proteins, have been identiﬁed as potentially very sensitive
targets for certain metal compounds, such as the nucleotide
excision repair protein xeroderma pigmentosum A (XPA), the
DNA damage signaling protein poly(ADP-ribosyl) polymerase 1
(PARP1), and the tumor suppressor protein p53 [6–16]. Respec-
tive inhibitions have frequently been observed at comparatively
low concentrations. Underlying mechanisms may be explained
either by disturbances of cellular redox homeostasis by metal
ions, i.e., the induction of oxidative stress, or by interactions of
metal ions with speciﬁc sites in proteins involved in cellular redox
regulation. With respect to the latter, there has been accumulat-
ing evidence that, for example, reversible redox reactions on
thiol/disulﬁde groups in proteins are involved in signal transduc-
tion processes similar to phosphorylation reactions [17–19].
Within this review, current evidence is summarized on the
role of oxidative mechanisms in metal-induced carcinogenicity,
with special emphasis on the potential impact on cellular redox
regulation.Cellular
respiration H2O + O2
Oxidative burst O2•-
SOD
H2O2
GPx H2O
Cd
Environmental 
GSH GSSG
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Fig. 1. Role of metal ions in the generation of cellular damage by reactive oxygen
species (ROS). Whereas redox-active transition metal ions or reactive intermedi-
ates such as Cr(V) may convert H2O2 into highly reactive HOd, redox-inactive
cadmium ions may increase the formation of ROS by inhibiting cellular defense
enzymes such as superoxide dismutase (SOD), catalase, and/or glutathione
peroxidase (GPx).Oxidatively damaged DNA and the impact of carcinogenic
metal compounds
Reactive oxygen species (ROS) such as superoxide anion
(O2d
), hydrogen peroxide (H2O2), and hydroxyl radical (HOd)
are by-products of cellular respiration, generated by incomplete
reduction of oxygen to H2O. To enable the use of oxygen for
energy production and yet to minimize oxygen-derived toxicity,
a complex antioxidant network has evolved including the scaven-
ging of reactive species by glutathione and vitamins; the enzy-
matic conversion of highly reactive oxygen species to less harmful
ones by superoxide dismutase, catalase, and glutathione perox-
idase; and ﬁnally the repair or elimination of damaged macro-
molecules. Oxidative stress occurs if the equilibrium between the
generation of ROS and the efﬁciency of detoxiﬁcation is disrupted.
Nevertheless, even under normal cellular conditions, protection is
not complete and a measurable amount of oxidatively damaged
macromolecules exists in mammalian cells [5]. Especially the
generation of elevated levels of DNA damage has been implicated
in carcinogenicity. Oxidatively generated DNA damage includes a
range of lesions such as DNA base modiﬁcations, sugar lesions,
DNA single- and double-strand breaks, DNA–protein cross-links,
DNA–DNA cross-links, and abasic sites. The main ROS identiﬁed
so far that lead to DNA damage are HOd, singlet oxygen (1O2), and
one-electron oxidants. Among these, only HOd is able to generate
DNA single-strand breaks as a consequence of initial hydrogen
abstraction from the 2-deoxyribose moieties, with different
probabilities of hydrogen abstraction in different positions
[20–23]. Concerning DNA single-base damage, 1O2 reacts speciﬁ-
cally with guanine, producing 8-oxo-7,8-dihydroguanine (8-oxo-
Gua) without further reaction products [24]. Furthermore,
8-oxoGua, as well as 13 other singly oxidized purine and pyr-
imidine bases, has been detected in cellular DNA, mediated by
HOd or high-intensity UVC laser pulses [25]. In addition to single-
base DNA damage, HOd and one-electron oxidants have beenshown to generate organic radicals such as radical cations, carbon
centered or peroxyl radicals, which are able to react further with
other DNA constituents or proteins, giving rise to more complex
DNA lesions such as intra- and interstrand DNA cross-links as well
as DNA–protein cross-links . Finally, DNA double-strand breaks
(DSBs) arise from one nick in each DNA strand within one or two
helix turns; they may, however, also be generated, for example,
by replication of damaged DNA due to collapse of stalled replica-
tion forks (for recent reviews see [26,27]). Among these, several
oxidatively generated DNA base modiﬁcations such as 8-oxoGua
have miscoding and thus premutagenic properties and therefore
may act as initiators in carcinogenesis [28]. Especially transition
metal ions play an important role in the induction of oxidatively
damaged DNA (Fig. 1). Whereas neither superoxide radical anion
nor hydrogen peroxide is able to react with DNA directly, in the
presence of transition metals such as iron, copper, cobalt, or
nickel H2O2 is converted into the highly reactive HOd by Fenton-
type reactions. Therefore, in the case of essential elements such as
iron and copper, the controlled uptake, protein-bound transport,
and intracellular sequestration of redox-active metal ions by
metal-binding proteins are one important prerequisite to protect
from elevated levels of oxidatively generated DNA damage.
However, this protection will be overwhelmed under conditions
of cellular overload by transition metals because of elevated
exposure and/or nonphysiological uptake routes such as inhala-
tion [5,29]. One unique example is Cr(VI). Under physiological
conditions, Cr(VI) enters the cell as the anionic tetrahedral species
chromate, CrO4
2 , via anion transport systems such as the sulfate
carrier, and is intracellularly reduced to Cr(III), described by the
so-called ‘‘uptake–reduction’’ model [30–32]. Within the cell,
reduction does not require enzymatic steps but is mediated by
direct electron transfer from ascorbate and nonprotein thiols such
as glutathione and cysteine; during this process, potentially toxic
intermediates such as oxygen and sulfur radicals are generated,
dependent on the intracellular reductant (for recent review see
[33]). DNA lesions generated after exposure to Cr(VI) consist of
two categories, namely oxidatively induced DNA damage and
DNA lesions resulting from Cr(III)–DNA interactions. With respect
to the formation of ROS during the intracellular reduction process,
several pathways have been proposed, including the reaction of
Cr(V)–glutathione complexes with hydrogen peroxide and the
formation of HOd and/or a one-electron reduction of Cr(VI) to
Cr(V) by NADPH-dependent ﬂavoenzymes [34,35]. Cr(V) may
either react with hydrogen peroxide in a Fenton-type reaction
to yield again HOd [36], and thus induce DNA strand breaks as
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guanine DNA bases [37]. With respect to the latter, the resulting
guanine radical is able to undergo hydration to give rise to
8-oxoGua and 2,6-diamino-4-hydroxy-5-formamidopyrimidine.
Furthermore, the guanine radical has been proposed to be the
key intermediate in oxidatively generated DNA–protein and
DNA–DNA interstrand cross-links [27] as described above. Never-
theless, the induction of oxidatively damaged DNA by Cr(VI)
appears to be restricted to high exposure concentrations [38].
Although the relevance of oxidatively induced DNA lesions under
physiological conditions has been questioned [39], especially
ternary Cr–DNA adducts may be of special importance for
chromate-induced carcinogenicity, in which Cr bridges DNA and
small molecules such as cysteine, histidine, glutathione, or ascor-
bate, presumably arising from preformed Cr–ligand complexes
during the reduction process. Under physiological conditions,
ascorbate appears to be the major reductant, and especially
ternary adducts formed from Cr–ascorbate are potent premuta-
genic DNA lesions [40]. Furthermore, these lesions lead to
aberrant mismatch repair (MMR) and upon chronic exposure to
toxic doses of Cr(VI) the selective outgrowth of MMR-deﬁcient
clones exerting a high degree of genomic instability has been
postulated [39,41]. Finally, metal compounds exerting no redox
chemistry such as cadmium may also contribute to elevated
levels of oxidatively damaged DNA, which may be attributed to
an inhibition of ROS-detoxifying enzymes such as superoxide
dismutase [3,5,29]. Last but not least, an inhibition of DNA repair
systems involved in the removal of oxidatively generated DNA
lesions may increase their steady-state levels upon chronic
exposure to metal compounds (see below). Because these inhibi-
tions have frequently been observed at far lower concentrations
compared to the induction of considerable amounts of oxidatively
generated DNA lesions, as shown, for example, in the case of
nickel and cadmium compounds [42], this may be particularly
relevant for metal-induced carcinogenicity.Role of ROS in cell signaling—chemical considerations
In addition to the induction of cellular damage to macromo-
lecules, there is accumulating evidence that ROS and reactive
nitrogen species (RNS) are also involved in cell signaling, acting as
second messengers and forming an integral part of the signal
transduction network [17–19,43,44]. Because of their chemical
properties and biological half-lives, each ROS reacts with pre-
ferred biological targets. Whereas HOd has indiscriminate
cellular targets and thus leads predominantly to damage to
macromolecules, O2
d and H2O2 may act as signaling molecules
(Fig. 2). O2
d is readily converted into H2O2 either spontaneously
or by superoxide dismutase; also, it can oxidize [Fe–S] clusters to
release iron, whereas its reactivity toward thiols is thought to be
not relevant in vivo. H2O2 may be toxic when converted to HOd
by reaction with transition metal ions via Fenton or Fenton-typeFig. 2. The concept of redox regulation. In addition to phosphorylation of critical
enzymes, reversible oxidation of deﬁned thiol and selenol groups seems to be a
second mechanism in the regulation of cellular signaling. Selectivity is given by
the reactivity of the respective thiol/selenol residues.reactions; however, it may also serve as a signaling molecule by
reaction with thiol groups of cysteine residues [43]. Reversible
oxidation of these residues yields sulfenic acid (–SOH) that can
form disulﬁde bonds with nearby cysteines (–S–S–); these mod-
iﬁcations may be reduced by thioredoxin and peroxiredoxin.
Further oxidation of sulfenic acid results in sulﬁnic acid (–SO2H)
or sulfonic acid (–SO3H), for which no reducing enzymatic system
has been discovered yet and which thus seems to be irreversible
under cellular conditions [45]. Therefore, the thiol/disulﬁde cou-
ple is ideally suited to redox modulation, serving as redox sensor
and a switch to alter protein structures and/or activities. Several
signaling pathways involved in cell proliferation and survival are
thought to be regulated via ROS (see below). However, because
signaling ROS concentrations are in the nanomolar concentration
range and the cellular thiol concentration including glutathione
(GSH) is in the millimolar concentration range, this raises the
question of how the speciﬁcity required for the activation or
inactivation of signal pathways is provided. Perhaps most impor-
tant, there are pronounced differences in the reactivity of thiol
groups toward ROS. One critical determinant is the pKa value of
the respective thiol group, which can differ between 8.7 for
cysteine in GSH and 3.5 for thiol transferase. Only those cysteine
residues predominantly deprotonated under physiological condi-
tions are well suited to participate in the ROS-mediated signal
transduction network (reviewed in [18]). Further speciﬁcity is
given by the respective protein, because the intermediate sulfenic
acid is stabilized by the microstructure of the protein as a
prerequisite for reversible disulﬁde formation and protection
from irreversible further oxidation [45]. Altogether, reaction rates
with thiols vary between 10 and 106 M1 s1, which ensures
selectivity under cellular conditions ([43] and references therein).
Cysteine can also participate in redox regulation by coordinating
zinc. Within zinc-binding structures, zinc is coordinated by four
cysteines and/or histidines. Zinc lowers the pKa of the coordinat-
ing thiols, providing a redox control via metal binding and release
on protein structure and function [46,47]. As a second amino acid,
selenocysteine, which is more reactive toward H2O2 because of its
low pKa, may operate in H2O2-induced redox regulation. Even
though the exact role of all selenoproteins in these processes has
not been established, thioredoxin reductases are required for the
regeneration of thioredoxins, which are important redox regula-
tors [17,43,48–51]. In addition to differences in the reactivity of
the thiol or selenol group of cysteines or selenocysteines, respec-
tively, the subcellular distribution of ROS or RNS seems to be
important. Whereas most techniques applied to detect ROS levels
measure overall changes within a cell, local levels at the actual
site of ROS generation are presumably much higher, enabling
selective oxidation of redox-sensitive proteins in the near sur-
rounding region [18].Redox regulation in cell signaling, stress response, and cellular
response to DNA damage
Several signaling pathways have been identiﬁed as redox
regulated via reversible oxidation and reduction of thiol groups.
It appears that on one side the redox status inside a cell is crucial
for the correct functioning of many enzymes and that on the other
side alterations in the redox status can serve as a signaling
mechanism to activate or inactivate distinct signaling and/or
DNA repair pathways. Thus, pro-oxidative changes in the intra-
cellular thiol/disulﬁde redox state or elevated concentrations of
H2O2 will lead to increased tyrosine phosphorylation in numerous
proteins, which in some cases may be the consequence of
oxidative inhibition of protein tyrosine phosphatases, probably
due to an oxidation of cysteine residues in the active site of these
A. Hartwig / Free Radical Biology and Medicine 55 (2013) 63–7266enzymes [52]. Other mechanisms include the reversible oxidation
of associated regulating proteins such as thioredoxin or Kelch-like
ECH-associated protein (Keap1) as well as the redox regulation of
zinc-binding structures found in protein kinase C, in many
transcription factors, in the tumor suppressor protein p53, and
in DNA repair proteins. ROS-regulated cellular signaling pathways
can be grouped into those affecting cell proliferation, survival,
differentiation, and metabolism; those belonging to the antiox-
idant and anti-inﬂammatory response; those regulating iron
homeostasis; and those induced in the frame of the DNA damage
response [19] (Fig. 3). For example, the apoptosis signal-regulated
kinase 1 (ASK1) is an upstream mitogen-activated protein kinase
kinase kinase (MAPKKK) that regulates the c-Jun N-terminal
kinase (JNK) and p38 MAPK pathways leading to apoptosis via
phosphorylation of MKK4, MKK3, and MKK6 MAPKKs and which
is activated under conditions of oxidative stress. One mechanism
of its activation consists in the oxidation of thioredoxin, which
constitutively interacts with ASK1 in its reduced form; upon
oxidation, thioredoxin dissociates from ASK1, allowing for oligo-
merization of ASK1 and subsequent autophosphorylation at Thr-
838 located within the kinase domain [53,54]. One other example
is the phosphoinositide 3-kinase (PI3K) pathway activated by
various growth factors and playing a key role in cell proliferation
and survival. PI3K catalyzes the synthesis of the second messen-
ger phosphatidylinositol 3,4,5-triphosphate (PIP3) and is nega-
tively regulated by the phosphatase and tensin homologue, which
dephosphorylates PIP3 back to phosphatidylinositol 4,5-bispho-
sphate, via disulﬁde bond formation between the Cys-124 und the
Cys-71 residues within the catalytic domain [55].
An important adaptation to oxidative stress consists in the
upregulation of antioxidant detoxiﬁcation genes. Two important
pathways are the redox factor 1 (Ref-1)-mediated activation of
transcription factors and the NFE2-like 2 (Nrf2) transcription
factor binding to the antioxidant-responsive element (ARE). Both
pathways depend on redox regulation. Ref-1 is a multifunctional
enzyme comprising both DNA repair and transcriptional regula-
tory activities. Whereas the AP endonuclease repair activity
(APE1) is located at the C-terminal region, the N-terminal region
is responsible for redox activity. Here, Cys-65 along with Cys-93 is
required to reduce and thereby activate targeted transcription
factors such as such as activator protein 1 (AP-1), fos-jun, p53,
hypoxia-inducible factor 1 (HIF-1a), and nuclear factor kB (NF-
kB). The reduction of Ref-1 appears to be regulated by thioredoxin
[19,56]. In addition to the oxidative stress response, redox
regulation of Ref-1/APE1 also affects basically all DNA repair
systems. By activating p53, AP-1, HIF-1a, and NF-kB, transcription
of DNA repair genes involved in homologous recombination,
nucleotide excision repair, base excision repair, and mismatch
repair is regulated by either activation or repression (for recentFig. 3. Cellular processes affected by redox regulation. Whereas O2
 is thought to
mediate iron release from [Fe–S] clusters, H2O2 may lead to a reversible oxidation
of redox-sensitive thiols groups involved in many processes required for main-
taining cellular and genomic integrity.review see [57]). With respect to the Nrf2–ARE pathway, speciﬁc
cysteines in the Keap1 serve as redox sensors. Their oxidation
results in the release of Nrf2 from the Keap1/cullin-3 E3-ubiquitin
ligase (Cul3) complex, preventing Nrf2 degradation and allowing
for Nrf2 nuclear translocation. Additionally, Nrf2 contains a
conserved cysteine located in the DNA binding domain (Cys-
514) redox-regulated by Ref-1. Therefore, at least two sequential
redox events are required for maximum transcriptional activation
of ARE-dependent genes, including genes involved in intracellular
redox balance (glutamate cysteine ligase, glutathione peroxidase,
thioredoxin (Trx), thioredoxin reductase (TrxR), and heme
oxygenase-1 (HO-1)) and phase II detoxifying enzymes (glu-
tathione S-transferase, NAD(P)H quinone oxidoreductase-1, and
UDP-glucuronosyltransferase) as well as the transporter multi-
drug resistance-associated protein. Frequently, the induction of
Nrf2-dependent genes is thought to be protective by inducing an
adaptive response toward genotoxic agents. Nevertheless, there is
accumulating evidence that Nrf2 and its downstream genes are
overexpressed in many cancer lines and human cancer tissues
and thus promote the survival of cancer cells on one side and
provide chemoresistance on the other [58]. Concerning DNA
damage response, ataxia–telangiectasia mutated (ATM) serves
beyond its function in DSB repair as a redox sensor, regulating
several genes in the oxidative stress response [59].
One example of a redox-regulated zinc-binding protein is the
tumor suppressor p53. P53 is weakly expressed in most cells and
stabilized by escape from proteasome-mediated degradation as a
response to various stress-related signals. Upon activation, it
accumulates in the nucleus, binds to DNA, and regulates the
transcription of many genes in addition to directly interacting
with proteins involved in DNA replication, transcription, and DNA
repair. Altogether, p53 provokes an antiproliferative response,
including cell cycle arrest, apoptosis, DNA repair, and differentia-
tion [60,61]. There are 10 conserved cysteines located in the DNA-
binding domain. Whereas redox changes may modify the
cysteines binding zinc (Cys-176, Cys-238, and Cys-242), thereby
changing the structure of p53, Cys-135, Cys-275, and Cys-277
may be directly involved in redox regulation of p53 function
[60–64].
In addition to p53, approximately 1% of the mammalian
genome encodes proteins containing a zinc-binding structural
motif in which zinc is tetrahedrally coordinated to four invariant
cysteine and/or histidine residues. In addition to transcription
factors such as SP1, TFIIIA, NF-kB, and MTF-1, several DNA repair
proteins such as XPA and PARP1 belong to this family of so-called
zinc-ﬁnger proteins, and zinc binding is a prerequisite either for
their DNA binding or for respective protein–protein interactions
required for transcription or DNA repair. Oxidation of the cysteine
residues within the zinc-binding motif leads to zinc release,
collapse of the structure, and inactivation of the respective
proteins, rendering them redox-sensitive [65,66].Impact of carcinogenic metal compounds on redox-sensitive
protein structures and interference with redox-controlled
DNA repair and signaling pathways
In metal-induced carcinogenicity, interactions with proteins
involved in cell growth, apoptosis, and the cellular response to
DNA damage seem to be of major importance, and there are
increasing numbers of studies demonstrating interactions with
signal transduction processes, tumor suppressor functions, and
DNA repair systems (for reviews see [1,4,7,8,67,68]). In some
cases, speciﬁc interactions with deﬁned signaling or DNA repair
proteins have been identiﬁed. One mechanism consists in the
competition between essential and toxic metal ions, such as
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carcinogenic metals exert high afﬁnities toward thiol groups,
rendering cysteine residues in proteins potentially particularly
sensitive targets. Thus, proteins with zinc-binding structures,
such as p53 and various DNA repair proteins, have been shown
to be inhibited by comparatively low concentrations of metal ions
or metal species. Also, many metal compounds induce redox-
regulated signal transduction pathways, which may be due to the
increased formation of ROS or to direct interaction with redox-
sensitive cysteines in signal transduction proteins. In most cases
the molecular interactions have not been fully explored experi-
mentally, but are subject of manifold current research activities.
To describe all interactions in detail is beyond the scope of this
review; instead, distinct examples are summarized.
Cadmium
Cadmium interacts with the expression of a large number of
genes, including stress response genes, immediate early response
genes, transcription factors, and translation factors. Major stress
response genes induced by cadmium are those involved in the
synthesis of metallothionein, encoding heat shock proteins,
involved in GSH synthesis and homeostasis, and those mediating
the oxidative stress response [67–72]. With respect to transcrip-
tion factors, cadmium exposure may lead to their activation
or inactivation, depending on the actual transcription factor
under investigation. Thus, c-fos and c-jun are overexpressed in
cadmium-transformed cells; they constitute the AP-1 transcrip-
tion factor, activating several genes involved in cell growth and
division. Other transcription factors activated by cadmium are
NF-kB and Nrf2. On the other hand, a suppression of the
transcription factor SP1 has been observed in cadmium-treated
cells (reviewed in [68,70]). In support of a role for a redox-
mediated mechanism in cadmium-induced activation of the
MAPK pathway, cadmium was shown to inhibit serine/threonine
phosphatases 2A and 5, leading to the activation of extracellular
signal-regulated protein kinase (ERK1/2) and JNK. This effect
was inhibited by N-acetyl-L-cysteine and resembled the effects
induced by hydrogen peroxide; therefore, the authors interpreted
this effect being due to the enhanced generation of ROS [73,74].
Nevertheless, because these phosphatases contain critical
cysteine residues [75], the impact of cadmium may also be
explained by a direct reaction with these cysteines. One other
example is the cadmium-induced activation of Nrf2 [76,77]. As
stated above, Keap1 sequesters Nrf2 in the cytoplasm and thus
serves as a negative regulator. After treatment of mouse embryo
ﬁbroblasts (MEFs) with cadmium, Nrf2–Keap1 were stabilized in
the cytoplasm and translocated to the nucleus, where the com-
ponents dissociated. This was followed by the induction of the
ARE-dependent expression of HO-1 in MEFs and in a respective
reporter gene assay [76].
In addition to a direct stimulation of mitogenic signals and to
the induction of the antioxidant defense system, cadmium inter-
feres with the structure and function of the tumor suppressor
protein p53. Two opposite effects have been reported, a stabiliza-
tion of p53 through phosphorylation followed by the induction of
the p53-mediated stress response [78–80], but also an inactiva-
tion of p53 via structural changes. As stated above, p53 contains a
zinc-binding structure in its DNA-binding domain, essential for its
tumor suppressor functions and rendering the protein redox-
sensitive . Zinc binding is thought not only to be structural but
also to mediate the redox control of p53. Exposure of either
isolated p53 protein or human breast cancer MCF7 cells to
cadmium resulted in the disruption of the zinc-binding structure,
yielding a so-called ‘‘mutant’’ conformation, inhibition of DNA
binding, and inhibition of the activation of p53 target genesincluding p21. Furthermore, suppression of the p53-mediated
cell cycle arrest in response to DNA damage induced by
g-irradiation was observed [81]. Similar effects were demonstrated
in A549 human lung tumor cells, in which CdO and CdCl2 induced
structural alterations of the zinc-binding domain of p53, followed
by diminished induction of the p53-regulated nucleotide excision
repair gene xeroderma pigmentosum group C (XPC) and dimin-
ished removal of UVC and benzo[a]pyrene diolepoxide-induced
DNA damage [15]. Thus, it appears that cadmium destroys
the zinc-binding structure of p53, either by replacing zinc or by
interaction with zinc-complexing thiols.
A similar mechanism may also account for the inactivation of
other DNA repair proteins and transcription factors. Thus, in
addition to the induction of mitogenic signaling and the inter-
ference with p53-mediated cell cycle control, cadmium has been
shown to impair almost all major DNA repair pathways, such as
nucleotide excision repair (NER), base excision repair (BER), and
mismatch repair (MMR), providing a plausible explanation for its
comutagenicity in combination with various DNA-damaging
agents, including UVC radiation and DNA alkylation agents, but
also for the induction of genomic instability by establishing a
mutator phenotype [1,3,67]. As for p53, redox-sensitive cysteine
residues either in zinc-binding structures or in other critical
positions are frequently found in DNA repair proteins or in
respective transcription factors of DNA repair genes. One major
redox regulator is Ref-1/APE1, regulating genes of NER, BER, and
MMR as well as DSB repair [57]. DNA repair proteins with zinc-
binding structures include the bacterial formamidopyrimidine–
DNA glycosylase (Fpg) involved in the removal of oxidatively
damaged DNA bases and the mammalian XPA protein essential
for the formation of the DNA damage recognition complex during
NER. Cadmium disturbed the activity of isolated Fpg and dimin-
ished DNA binding of XPA to a UVC-irradiated oligonucleotide
[9,82]. One molecular mechanism related to the inactivation of
zinc-binding proteins appears to involve the displacement of zinc
by cadmium, even though the radius of the Cd2þ ion is larger
compared with Zn2þ [7,8,71,83]. This is, for example, evident
from the reversal of cadmium-inhibited binding of isolated XPA
to UVC-damaged DNA by excess of zinc [82] as well as from
structural investigations of XPA or a peptide resembling the zinc-
binding domain of XPA [84,85]. With respect to the latter, binding
constants for Cd2þ were found to be about 1000-fold higher
compared to Zn2þ . Even though the displacement of zinc by
cadmium led to only minor structural alterations, detailed studies
in cadmium-treated A549 cells revealed an impaired assembly/
disassembly of the DNA damage recognition proteins XPC and
XPA at the repair complex after UVC irradiation [15]. With respect
to BER, cadmium has been shown to inhibit the activity of the
human 8-oxoguanine glycosylase (hOGG1) activity responsible
for recognition and excision of the premutagenic
8-oxodG during BER in mammalian cells [86–88]. Inhibition of
the repair of oxidative DNA base damage has also been observed
in vivo in rat testis [89]. Concerning the potential underlying
mechanisms, the data provide no clear picture, but both are
consistent with an interference with critical thiols: whereas some
studies suggest the inhibition of the enzyme by cadmium as such,
perhaps by interacting with cysteines essential for enzyme
activity [86,90], data of another study rather support the dimin-
ished DNA binding of the zinc-ﬁnger-containing transcription
factor SP1 to the OGG1 promoter [91], which in turn appears to
be due to the displacement of zinc by cadmium [92].
One other example is PARP1, which plays a complex role in
DNA damage signaling in BER as well as in drug-induced and
spontaneous apoptosis and which contains three zinc ﬁngers
involved in the recognition of DNA breaks and the subsequent
synthesis of poly(ADP-ribose) [93,94]. In HeLa cells, H2O2-induced
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interactions are currently being explored in our laboratory.
Arsenic
As is the case for cadmium, arsenic has also been shown to
interact with signal transduction systems, tumor suppressor func-
tions, and DNA repair systems. Nevertheless, in contrast to cad-
mium, whose Cd2þ ions appear to be the ultimate species reacting
predominantly with proteins, speciation seems to be an important
issue in arsenic-induced carcinogenicity. With regard to environ-
mental human exposure to inorganic arsenic, arsenate and arsenite
are the principal species of concern. After inhalation or ingestion,
humans and many other mammals metabolize inorganic arsenic
into organic forms. After reduction of arsenate, arsenite is metabo-
lized to trivalent and pentavalent methylated species, namely
monomethylarsonous (MMA(III)) and dimethylarsinous (DMA(III))
acid and monomethylarsonic (MMA(V)) and dimethylarsinic
(DMA(V)) acid. Various metabolic pathways have been proposed,
consisting of either successive oxidative methylation and reduction
steps or—more recently—including glutathione conjugation and
subsequent methylation to the aforementioned metabolites
[96–98]. Thus, when considering interactions of arsenicals with
redox-regulated cellular processes, the respective species are
expected to exert distinct reactions. Oxidative stress and thus
elevated levels of ROS and RNS are thought to be important
mechanisms in arsenic-induced carcinogenicity. Underlying
mechanisms may be manifold and include their generation during
metabolism, their interactions with the respiratory chain, the release
of iron from ferritin, and modulation of NO synthases (reviewed in
[1,5,99,100]). Moreover, arsenicals have been shown to interfere
with cellular redox homeostasis by decreasing the cellular GSH
content, either by complexing thiol groups, resulting in GSH binding
and depletion and consumption of GSH during arsenic metabolism,
or by interactions with glutathione-related enzymes [101,102]. In
general, trivalent arsenicals such as arsenite and MMA(III) exert
higher afﬁnities for dithiol or trithiol sites in proteins compared to
monothiol sites [103].
Arsenite has been shown to activate several redox-regulated
signaling pathways, including all three classes of MAPKs
[104–108]. Thus, for example, in a mesencephalic cell line
arsenite at low, noncytotoxic concentrations activated NF-kB
and AP-1 and induced phosphorylation of ERK1/2 [104]. One
other transcription factor activated by arsenite is Nrf2, leading to
the expression of antioxidant enzymes via AREs. Nevertheless, the
underlying mechanisms appear to be complex and are not readily
understood at present. For example, within Nrf2, cysteines 191,
235, 311, 316, 414, and 506 are critical for arsenite sensing and
responsiveness [109], whereas within Keap1 Cys-151 is required
for arsenic recognition and responsiveness by Nrf2 [110]. In
another study applying a reporter gene system both As(III) and
MMA(III) were able to activate Nrf2 by increasing the association
between Keap1 and Cul3, thereby disrupting the dynamic assem-
bly/disassembly process of the Keap1–Cul3 E3 ubiquitin ligase
complex. Reduced E3 ubiquitin ligase activity led to decreased
degradation of Nrf2 and activation of the Nrf2 downstream
effects. Here, upregulation of Nrf2 by As(III) and MMA(III) was
independent of Cys-151 in Keap1 [111].
Published data concerning the impact of arsenite on the tumor
suppressor protein p53 are controversial at present and seem to
depend on cell line and incubation time. Thus, arsenite induced
accumulation of p53 in human ﬁbroblasts and a human lympho-
blastoid cell line via an ATM-dependent pathway [112,113].
On the other hand, p53 function has been shown to be inactivated
by arsenite and MMA(III). Thus, MMA(III) led to a marked
impairment of p53 induction in response to benzo[a]pyrenediolepoxide and reduced p53 DNA binding. In the same study, a
p53-null cell line did not exhibit an inhibition of nucleotide
excision repair by MMA(III), indicating that p53 is involved in
arsenical-induced DNA repair inhibition [114]. Similarly, arsenite
and MMA(III) were shown to decrease the expression levels of the
nucleotide excision repair genes XPC and XPE, mediated by p53 as
transcription factor [14]. This may be due to the unfolding of the
zinc-binding domain of p53, yielding the so-called mutant con-
formation, as has been shown after treatment of human SV-40-
immortalized uroepithelial cells after treatment with arsenite
[115]. Interestingly, after long-term exposure of human skin
keratinocytes an inactivation of p53 was found to be mediated
via poly(ADP-ribosyl)ation of p53, despite a globally reduced level
of poly(ADP-ribosyl)ation [116].
One important mechanism in arsenic-induced carcinogenicity
appears to be the interaction with DNA repair systems. The most
sensitive target related to DNA repair affected by trivalent arsenicals
is poly(ADP-ribosyl)ation. Thus, low-nanomolar concentrations of
arsenite, MMA(III), and DMA(III) inhibited poly(ADP-ribosyl)ation in
human HeLa cells, whereas the pentavalent species MMA(V) and
DMA(V) were not inhibitory. Furthermore, all three trivalent arseni-
cals inhibited isolated PARP1, indicating a direct interaction with
this enzyme [13,117,118]. How these ﬁndings are explained in view
of the poly(ADP-ribosyl)ation of p53 after long-term exposure to
arsenite described above [116] is currently not understood but
certainly deserves further attention. Trivalent but not pentavalent
arsenicals have also been shown to inhibit NER at low, noncytotoxic
concentrations. In this context, the removal of UVC- and benzo[a]-
pyrene diolepoxide-induced DNA lesions was impaired by arsenite
and even more pronounced by MMA(III) and DMA(III) in cultured
cells and laboratory animals (for review see [1,100] and references
therein). As an underlying mechanism involved in NER inhibition,
interactions with zinc-ﬁnger NER proteins may be plausible. Thus,
trivalent but not pentavalent arsenicals have been shown to release
zinc from a 37-amino-acid peptide resembling the zinc-ﬁnger
domain of the human XPA protein (XPAzf) [119], albeit by different
mechanisms. Whereas equimolar concentrations of MMA(III)
mediated zinc release, forming mono- and diarsenical derivatives
of XPAzf, a 10-fold excess of arsenite was required to partially
oxidize XPAzf, yielding one or two disulﬁde bonds [120]. With
regard to the inhibition of NER in cells, arsenite and—again at even
lower concentrations—MMA (III) were shown to inhibit the associa-
tion of the damage recognition protein XPC to the site of UVC-
induced DNA damage. Along with diminished gene expression of
XPC and XPE and a reduced XPC protein level, this may be explained
by reduced activity of p53, which serves as a transcription factor for
both DNA repair genes, perhaps due to unfolding of the zinc-binding
structure within the DNA-binding domain described above [14,115].
Finally, arsenite and its methylated metabolites inhibited BER
[11,121–124]. One explanation consists in the inhibition of PARP1
[124]. In addition, other key BER proteins are affected as well. When
investigating hOGG1 function as well as gene and protein expression
of major BER proteins, pronounced differences in the respective
arsenic species were observed. Thus, cellular OGG activity was
diminished most pronouncedly by DMA(V), DNA ligase IIIa by
arsenite, and XRCC1 protein level by MMA(V). The trivalent meta-
bolites MMA(III) and DMA(III) exerted inhibitory effects only at
cytotoxic concentrations. Nevertheless, by comparing cellular effects
with interactions of the respective isolated enzymes, it became
apparent that most probably different intracellular species are
generated, which mediate the observed inhibitions [11].
Chromium(VI)
In the case of Cr(VI) the formation of DNA adducts appears to
play an important role in generating genomic instability and thus
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effects of Cr metabolites formed during reduction of Cr(VI) to
Cr(III), chromate has been shown to activate various redox-
sensitive signal transduction pathways, presumably due to the
generation of ROS during the reduction process (summarized in
[33]). Thus, Cr(VI) has been shown to induce NF-kB and AP-1 in a
time- and dose-dependent manner in a mouse macrophage cell
line and in Jurkat cells. The induction of AP-1 was associated with
the phosphorylation of MAP kinase p38 and JNK, but independent
of ERK [125,126]. This argues against a direct interaction of Cr(VI)
with the respective kinases but rather points to the role of
intracellular reduction and intracellular generation of ROS, ser-
ving as an upstream signal for the activation of AP-1 and NF-kB
via p38 and IkB kinase [33]. Nevertheless, an activation of ERK1
and ERK2 was observed in rat hepatoma cells, with a concurrent
increase in the intracellular levels of H2O2 [127]. Further support
for an interference with redox-regulated proteins by Cr(VI) is
provided by the irreversible inhibition of TrxR and the selective
oxidation of Trx’s and peroxiredoxins in BEAS-2B as well as in
primary normal human bronchial epithelial cells under conditions
where only very few other cellular proteins were oxidized, thus
excluding indiscriminate thiol oxidation. Candidate reactive inter-
mediates causing this interference are Cr(V), Cr(IV), and HOd
[128]. As opposed to cadmium and arsenite, the inactivation of
p53 does not seem to play a predominant role in chromium-
induced carcinogenicity; this is also evident from the fact that
chromate-induced tumors retained wild-type p53 [33]. Instead,
Cr(VI) activates p53 in A549 human lung tumor cells by increas-
ing the protein level as well as by enhancing the DNA binding and
transcriptional activity via increased generation of ROS [129,130].
With respect to the antioxidative stress response, Cr(VI) activated
the Nrf2–Keap1 signaling pathway by inhibition of ubiquitination
of Nrf2, causing accumulation of Nrf2 in the nucleus and tran-
scription of ARE-driven genes [131].Fig. 4. Proposed model for carcinogenic metal-induced oxidative stress, interaction wit
of ROS may lead to ROS-induced cell signaling and to damage to cellular macromolecu
activation or an oxidative distortion of redox-sensitive protein structures, such as zinc
metal ions with high afﬁnity toward thiols may directly react with redox-sensitive stru
tumor suppressor functions. In the case of signal transduction pathways, this may lead
reactions may give rise to a high degree of genomic instability.Concerning DNA repair inhibition, an interference with NER
has been observed, as evidenced by an impaired removal of UVC-
induced pyrimidine dimers and benzo[a]pyrene-induced DNA
lesions. Nevertheless, instead of the inactivation of distinct
proteins in this repair pathway, the inhibition was suggested to
be due to the competition with the repair of Cr–DNA adducts,
which is mediated via NER as well (for a summarizing discussion
see [41]).Conclusions and perspectives
In conclusion, there is accumulating evidence that ROS may
play an important role in the regulation of manifold cellular
processes [17,19]. Especially the thiol/disulﬁde couple may serve
as a sensitive redox sensor; speciﬁcity seems to be mediated by
pronounced differences in their reactivity toward H2O2 in the
respective proteins [18,43]. Furthermore, the induction of oxida-
tive stress and the interference with redox-regulated cellular
processes may be important issues with several facets in metal-
induced carcinogenicity (summarized in Fig. 4). First, transition
metal ions may catalyze Fenton-type reactions, which generate
elevated levels of HOd, leading to damage of all major classes
of cellular macromolecules. Especially oxidatively generated
damage to DNA bases may play a role in the initiation step of
carcinogenicity. Nevertheless, in the case of several metal com-
pounds, concentrations required in cell culture systems to achieve
a signiﬁcant increase in oxidatively generated DNA damage were
quite high, questioning the relevance of DNA damage induced by
ROS in metal-induced carcinogenicity under realistic exposure
conditions. Also, because oxidatively generated DNA lesions are
repaired quite effectively [132], their transient increase at ele-
vated metal concentrations would not be expected to sufﬁciently
explain metal-induced carcinogenicity. Second, metal compoundsh redox-sensitive protein structures, and cellular consequences. (A) Elevated levels
les, depending on the type of ROS. In the case of proteins, this may lead to either
-binding structures in transcription factors or DNA repair proteins. (B) Especially
ctures in proteins, thereby inhibiting DNA repair processes, cell cycle control, and
to persistent mitotic cell signaling and stress response. Altogether, both lines of
A. Hartwig / Free Radical Biology and Medicine 55 (2013) 63–7270may increase the levels of ROS such as H2O2, leading to an
activation of redox-sensitive signaling pathways. This may also
occur indirectly, for example, by inactivation of ROS-detoxifying
enzymes such as superoxide dismutase, glutathione peroxidase,
or catalase. Third, metal ions may react with redox-sensitive
protein domains or amino acids directly, thereby either inactivat-
ing redox-sensitive protein structures, such as the zinc-binding
domain of p53, or activating redox-sensitive signaling pathways.
Concerning the latter, different from H2O2-induced signaling, this
could even lead to persistent activation of mitogenic signaling, for
example, owing to an inactivation of phosphatases. Whatever
mechanism is most relevant depends on the actual metal ion or
metal species under consideration and more research is needed to
further unravel this issue. Altogether, the interference by metal
ions with redox regulation involved in growth stimulation and
control, DNA repair, and apoptosis frequently observed at low,
noncytotoxic concentrations may lead to genomic instability and
thus contribute to metal-induced carcinogenicity.Acknowledgment
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